Clinical trial · Interventional
The Effect of Catheter Protector on Catheter Dwell Time and Complications
Effect of a Catheter Protector on Dwell Time and Complications of Peripheral Intravenous Catheters in Oncology Patients: A Randomised Controlled Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study assessed the impact of IV House UltraDressing on PIVC dwell time and related complications in adult oncology patients.Adults hospitalised on an oncology ward between October 15, 2024 and May 22, 2025 were randomly allocated to an intervention group (transparent dressing plus IV House UltraDressing) or a control group (transparent dressing only). Data were collected using descriptive and catheter monitoring forms, and phlebitis was assessed using a 0-4 grading system.Outcomes included catheter dwell time, complication-related removals, and the distribution of non-infectious complications.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Complications | — | UNRESOLVED | — |
| Peripheral Catheterization | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| I.V. House UltraDressing | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- I.V. House UltraDressing
- description
- The nurse who will perform the PVC will clean the area where the PVC will be applied with alcohol and cotton wool, let it dry and apply Teflon Introcan Safety I.V. Catheter No. 22-24 (B. Braun Medical Inc. Bethlehem, PA, USA) to the patients and apply the routine intravenous line fixation method of the clinic with a plaster. The patient with the PVC will then fill out an introductory information form. I.V. House UltraDressing (I.V. House, Inc., St. Louis, MO, USA) will be applied according to the manufacturer's instructions and secured with an anti-slip tape without the need for further taping. Catheter-induced complications such as dislodgement, phlebitis, infiltration, extravasation, catheter occlusion and folding of PVCs will be observed and recorded on the PIVC Monitoring Form, Phlebitis Assessment Scale, and the Infiltration Scale and the effect of I.V. House UltraDressing will be evaluated.
- interventionNames
- Device: I.V. House UltraDressing
- type
- NO_INTERVENTION
- label
- Control
- description
- The nurse who will perform the PVC application will clean the area where the PVC will be applied with alcohol and cotton wool and leave it to dry, and the patients in both groups will be applied with a Teflon Introcan Safety I.V. Catheter (B. Braun Medical Inc. Bethlehem, PA, USA) numbered 22-24 and the clinic's routine intravenous line fixation method of fixation with a plaster will be applied. After the PVC is inserted, the introductory information form will be filled out and the duration of the stay of the PVC in the vascular access, dislodgement status and catheter-related complications such as dislodgement, phlebitis, infiltration, extravasation, catheter occlusion and folding of the PVCs will be observed and recorded on the PIVC Monitoring Form, Phlebitis Assessment Scale, and the Infiltration Scale form prepared by the researcher. Patients will remain in the study as long as they are hospitalized in the clinic and their PVCs are inserted.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Inclusion Criteria * Hospitalized in the oncology clinic * The one with the PVK attached, * Volunteered to participate in the research, * Treated in the same clinic during the study period, * No verbal, perceptual and visual communication problems, * 22-24 G (Blue) size catheter used, * Between the ages of 18 and 65, * Literate, -- Patients without scar tissue, infection, hematoma, edema at the sites to be used for PVK placement and successful PIVC placement on their first attemptwere included in the study. Exculision Criteria: * \- With a clotting disorder, * Patients with problems with skin integrity or limb movement such as scar tissue, infection, hematoma, edema at the PVK site, * Blood or blood products given through a catheter, * Patients who wanted to leave, were referred to a different clinic or discharged during the study were excluded from the study.
References
Publications (0)
Data not yet available